Status: Not yet recruiting
Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma
This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. This study will evaluate whether omitting Level Va irradiation in patients without these risk features does not compromise regional control or survival, with the goal of providing robust evidence to guide further personalization of NPC radiotherapy.
Participants needed: 474
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Fujian Cancer HospitalUpdated: Dec 8, 2025Locations: 1
Eligibility criteria
Pathologic diagnosis (pathologically confirmed by nasopharyngeal biopsy) was nas... [+4]
Ipsilateral Level IIb involvement; [+12]